Form 4 for GNTX GENTEX CORP
Accepted 2022-02-22 00:00:00 ET · period of report 2022-02-17 · accession 0001562180-22-001655 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-22 | 2022-02-17 | GNTX | Boehm Neil | CTO | A - Grant | $0.00 | +7,026 | 36.2K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-17 | A | A | 7,026 | $0.00 | 36,213 | D | — | — | (F1) These shares vest 100% three years from grant award date. (F2) Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. |